Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
about
Pharmacological interventions for pain in children and adolescents with life-limiting conditionsBisphosphonate treatment for children with disabling conditions.Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta.Current and emerging treatments for the management of osteogenesis imperfecta.A randomized, double blind, placebo-controlled trial of alendronate treatment for fibrous dysplasia of bone.The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta.Modeling the benefits of pamidronate in children with osteogenesis imperfecta.Does the use of a specialised paediatric retrieval service result in the loss of vital stabilisation skills among referring hospital staff?Bisphosphonate treatment of bone diseaseEffectiveness of pretreatment in decreasing adverse events associated with pamidronate in children and adolescents.Systematic review of effectiveness of bisphosphonates in treatment of low bone mineral density and fragility fractures in juvenile idiopathic arthritisIntravenous pamidronate treatment of infants with severe osteogenesis imperfecta.Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type ITreatment of osteogenesis imperfecta: who, why, what?Bisphosphonate treatment in the oim mouse model alters bone modeling during growthBone mineral density in developing children with osteogenesis imperfecta: a longitudinal study with 9 years of follow-up.Short-term efficacy of monthly pamidronate infusion in patients with osteogenesis imperfecta.SAPHO Syndrome Diagnosis and Treatment: Report of Five Cases and Review of the Literature.Osteogenesis imperfecta: recent findings shed new light on this once well-understood condition.The use of zoledronic acid in pediatric cancer patients.Does loss of spasticity matter? A 10-year follow-up after selective dorsal rhizotomy in cerebral palsy.Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age.Femoral neck fractures in osteogenesis imperfecta treated with bisphosphonates.Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment.Pamidronate treatment of steroid associated osteonecrosis in young patients treated for acute lymphoblastic leukaemia--two-year outcomes.Metaphyseal bands in osteogenesis imperfecta.Pamidronate treatment of less severe forms of osteogenesis imperfecta in children.Evaluation of a Modified Pamidronate Protocol for the Treatment of Osteogenesis Imperfecta.Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation.Functioning and quality of life in adults with mild-to-moderate osteogenesis imperfecta.Safety and efficacy of intravenous zoledronic acid in paediatric osteoporosis.Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?A prospective cohort study investigating gross motor function, pain, and health-related quality of life 17 years after selective dorsal rhizotomy in cerebral palsy.Divergent roles of immune cells and their mediators in pain.Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta.Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years.
P2860
Q24187283-27309482-23A3-487A-B41A-A006A606CE88Q33680621-F51A5DDD-63D1-400B-91C9-62CD784DB2FEQ34114280-FF189404-6962-42DC-9B16-8D39E9DC234AQ34133308-C1AAE307-328C-4C33-98C6-A6A00E04ED3CQ34429461-2E9CA070-36C0-487F-A13A-E4B736B5C80AQ34815287-0185B94B-5E6B-42D7-B738-8417977F0C6FQ34816036-9995D67D-E261-46C0-8A4B-1F996F5C7C26Q35274303-6F6DCB15-8DE1-4DC0-A790-1D292311B451Q35283631-9168FE2A-2279-44AD-ACB5-694FEC842DDAQ35681178-07D3230E-D569-45B3-A2B8-4089A085188DQ36153306-817A805D-DBA4-42CF-A62B-AF5927021A34Q36155282-198E1668-A5E4-4675-860E-4D6520D71CE4Q36194937-2F7BE1DD-1BEC-44AA-9A44-2373206DC5A7Q36500182-E59D5F4E-E4C3-4E55-9E6C-DB8B3A1D94EAQ37050007-747F73FE-A439-4817-AA77-1E811AE20340Q37079651-B1D1D924-9F8A-4E19-B23F-16FEBA8DF85EQ37158425-4C20B39B-EEEC-4B28-918A-C313F4A45A95Q37220329-F71E9E64-138F-4B5D-873A-2524F905A6CFQ37464691-8DF501D2-BD97-474C-B4BB-5A32FF5EE40AQ37522199-25D2691B-2555-4FE8-88A3-6B0406A33561Q37836669-97D2A996-162A-467F-AF64-6DE78031FEC6Q37876455-F87D0D2D-F1AF-4F21-834B-9934C75A3E32Q38260590-525850D6-C009-47B6-979A-666E88B85B14Q38615041-4F8C5899-8868-41AB-A86A-C52F8C347055Q38918970-C106867D-B050-4DCE-983F-D64C839F6F1DQ39353352-37E5C278-8E1F-4535-8065-1D6AA58D3F13Q39776685-CF57DF59-D0DF-47BD-BFA0-FF0200AE2E47Q40464515-4F52D6DC-B459-41EA-92E0-B223FA2555A7Q41342134-22697550-96DC-4F9E-A363-6BF61F2E8248Q43716531-8D388E2C-CFA6-4151-B1A5-1F1D2A422C0DQ43967980-9E0F7CB2-3F3B-4FB2-9EB7-A4276C2F12C5Q46062739-A85BEC37-E206-448A-A132-DFF6CCB7DBC7Q46790362-699BAF4E-40CA-46B2-BD70-2EFD6544FE68Q48055690-24C6E4A7-9CD6-41EC-90FE-AACEDCCE1393Q50426470-614D7D03-87C0-4DC1-A0D9-594B8630A9D0Q53234366-76EB15B7-2035-4312-B6EE-B3E33801584AQ53472422-0AB1994E-F442-466B-BD71-ED52A314B760
P2860
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@ast
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@en
type
label
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@ast
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@en
prefLabel
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@ast
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@en
P2860
P356
P1476
Beneficial effect of long term ...... ent of osteogenesis imperfecta
@en
P2093
P2860
P304
P356
10.1136/ADC.86.5.356
P407
P577
2002-05-01T00:00:00Z